Sequela is a small, renal-focused research organization dedicated to revolutionizing the prevention and management of chronic kidney disease (CKD) on a global scale. With expertise from leaders in diagnostics development, as well as healthcare delivery innovation, Sequela is paving a new path for CKD diagnosis and health outcome improvement. We are a family-owned company with headquarters in Pewee Valley, Kentucky. Founded in 2005, our core mission is to help science serve mankind. Our newly developed screening / diagnostic test is set to empower patients who are silently suffering from kidney dysfunction to take control of their own health and wellness. Our mentor-based, student development framework has remained central to our organization’s success. By working with future-clinicians and researchers, we are growing a sustainable network of innovative minds aiming to understand and prevent chronic conditions. Connect with us at https://SequelaBiotech.com